Investing on a budget can still be lucrative. And even though the best stocks tend to attract plenty of attention from investors who bid up their share prices, it’s possible to find quality companies trading for less than $50.
Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY), two pharmaceutical giants, are excellent examples. These stocks aren’t just affordable; they look like great value buys right now, and as a bonus, they’re solid dividend payers, too. Let’s dig in.
Pfizer has had poor financial results over the past few years. Investors are also concerned that it may struggle to address upcoming patent cliffs, including that of Eliquis, an anticoagulant set to lose patent exclusivity by the end of the decade.